Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. Jan. 24, 2019. Matt Wetzel.

Executive Summary

Device industry trade group AdvaMed has issued a revised version of its broadly used Code of Ethics. The new document, set to take effect on Jan. 1, 2020, discusses how device firms can work with health-care professionals to deliver high-quality, innovative care, without violating ethical principles or anti-bribery laws. See what AdvaMed's Matt Wetzel said about it here.

"We really tried to focus on making it a document that the user wants to read, wants to look at, wants to understand. Throughout the document we have new layout, new visuals, new elements. A compliance program isn't effective if it’s not being used or read, and another key component is that accessibility." –Matt Wetzel, VP and assistant general counsel, AdvaMed

Click here for a free trial of Medtech Insight


Related Content

AdvaMed Code Update Focuses On Compliance Standards





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts